Real-world outcomes of patients with metastatic breast cancer (BC) treated with osteoclast inhibitors (OIs).

e19314Background: Patients with metastatic BC have a high incidence of bone metastasis with associated morbidity and mortality. OIs including denosumab and zoledronic acid reduce the rate of skelet...